C4 Therapeutics (CCCC) Stock Chart & Stock Price History $2.42 +0.20 (+9.01%) Closing price 07/23/2025 04:00 PM EasternExtended Trading$2.39 -0.03 (-1.24%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock C4 Therapeutics Stock Price Performance The C4 Therapeutics (CCCC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 59.26%, with a year-to-date return of -32.78%. In the past month, the stock has increased 55.13%, reflecting recent market activity. As of the latest close, C4 Therapeutics traded at $2.42 with a market cap of $171.84 million and volume of 1.37 million shares. Receive CCCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for C4 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.31%1 Month Performance+55.13%3 Month Performance+50.31%Year-To-Date Performance-32.78%1 Year Performance-59.26% CCCC Stock Chart for Thursday, July, 24, 2025 CCCC Chart by TradingView C4 Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/23/2025$2.22$2.42+9.01%$2.53$2.191.37 million shs$171.84 million07/22/2025$2.27$2.22-2.20%$2.30$2.15869,811 shs$157.64 million07/21/2025$2.32$2.27-2.16%$2.48$2.261.31 million shs$161.19 million07/18/2025$2.18$2.32+6.42%$2.71$2.233.95 million shs$164.74 million07/17/2025$2.02$2.18+7.92%$2.26$1.922.23 million shs$154.80 million07/16/2025$2.11$2.02-4.27%$2.23$2.011.29 million shs$143.44 million07/15/2025$2.38$2.11-11.34%$2.39$2.101.70 million shs$149.83 million07/14/2025$2.23$2.38+6.73%$2.40$2.142.44 million shs$169.00 million07/11/2025$1.99$2.23+12.06%$2.41$1.934.06 million shs$158.35 million07/10/2025$2.02$1.99-1.49%$2.04$1.891.33 million shs$141.30 million Get the Latest News and Ratings for CCCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for C4 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/09/2025$1.71$2.02+18.13%$2.17$1.733.46 million shs$143.44 million07/08/2025$1.52$1.71+12.50%$1.80$1.531.57 million shs$121.43 million07/07/2025$1.49$1.52+2.01%$1.53$1.44569,579 shs$107.93 million07/04/2025$1.49$1.49$1.56$1.44728,171 shs$105.81 million07/03/2025$1.52$1.49-1.97%$1.56$1.44728,171 shs$107.93 million07/02/2025$1.51$1.52+0.66%$1.53$1.431.77 million shs$107.94 million07/01/2025$1.43$1.51+5.59%$1.60$1.401.07 million shs$107.23 million06/30/2025$1.40$1.43+2.14%$1.48$1.40677,845 shs$101.54 million06/27/2025$1.52$1.40-7.89%$1.55$1.408.24 million shs$99.41 million06/26/2025$1.54$1.52-1.30%$1.56$1.47676,705 shs$107.94 million06/25/2025$1.56$1.54-1.28%$1.57$1.48471,392 shs$109.36 million06/24/2025$1.47$1.56+6.12%$1.63$1.49941,694 shs$110.77 million06/23/2025$1.42$1.47+3.52%$1.47$1.36817,223 shs$104.39 million Related Companies Iovance Biotherapeutics Stock Chart Urogen Pharma Stock Chart Tilray Brands Stock Chart Tango Therapeutics Stock Chart Stoke Therapeutics Stock Chart Prime Medicine Stock Chart Dianthus Therapeutics Stock Chart Phathom Pharmaceuticals Stock Chart Upstream Bio Stock Chart Xencor Stock Chart Receive CCCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for C4 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CCCC) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding C4 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share C4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
